A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
Amir Abbas Tahami MonfaredWeicheng YeAditya SardesaiHenri FolseAmeya ChavanElena AruffoQuanwu ZhangPublished in: Neurology and therapy (2023)
ClinicalTrials.gov identifier, NCT03887455.